Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Epidemiology

Abstract 2547: Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers

Carlos Benitez-Buelga, Tereza Vaclova, María Sofia Ferreira, Nora Soberon, María Antonia Blasco, Ana Osorio and Javier Benitez
Carlos Benitez-Buelga
Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tereza Vaclova
Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Sofia Ferreira
Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora Soberon
Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Antonia Blasco
Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Osorio
Human Genetics Group, Spanish National Cancer Research Center (CNIO), and Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Benitez
Human Genetics Group, Spanish National Cancer Research Center (CNIO), and Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2016-2547 Published July 2016
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA

Abstract

Oxidative stress is a source of DNA damage which can lead to genomic instability and telomere shortening. The OGG1 glycosidase plays an important role in the Base Excision Repair (BER) pathway that counteracts the oxidative DNA damage caused by endogenous cell stress. Recently, we have demonstrated that a single nucleotide polymorphism (SNP) in the OGG1 gene can modify cancer risk in carriers of germline mutations in the BRCA1 and BRCA2 genes1. Hence, we aimed to explore the possible role of this variant in DNA damage and telomere shortening to explain the association of this cancer risk variant.

We used 2 independent set of samples with a heterogeneous BRCA mutational status.

First of all, a familiar breast and ovarian cancer (FBOC) set of 154 BRCA patients (BRCA1, BRCA2 and BRCAX) and 68 controls, were used to measure the mRNA OGG1 expression levels in blood and the leukocyte telomere length (TL).

Second, we used a panel of 23 Lymphoblastoid Cell Lines (LCL) from patients harboring germline mutations in BRCA1 and non-carrier controls to validate previous results regarding OGG1 mRNA expression levels and telomere shortening. Additionally we measured gammaH2AX intensity levels in LCL to evaluate the role of the SNP on DNA damage.

In the FBOC series, we found that the carriers of the variant had significant decreased expression levels of the OGG1 transcript compared with the non-carriers (p = 0.013). Regarding TL studies, we found that the variant may exert a synergistic effect together with BRCA1/2 mutations on telomere shortening (p<0.0045). TL was not associated to higher cancer risk in our FBOC series, pointing to this phenotype not as the cause of the cancer risk association, but maybe as a hallmark of a higher DNA damage environment when both genetic events are present in the cell.

Using the LCL panel we were able to detect OGG1 mRNA down regulation due to the presence of the variant and a significant telomere shortening exclusively in the BRCA1 defective cells harboring the OGG1 SNP after 55 passages. The DNA damage studies, confirmed significant higher intensity levels of gammaH2AX in the damaged LCL harboring the SNP compared to those not harboring it (p<0.0001).

These results, may explain the molecular insights behind this modifier variant. Under the prism of a deleterious interaction, in cells harboring mutations in BRCA genes, the presence of the SNP itself, seems to affect OGG1 mRNA down regulation. This could lead to a defective performance of the BER pathway that may lead to genome instability, characterized by higher gammaH2AX intensity in damaged cells and telomere shortening when both genetic events are present, and as consequence, higher cancer risk.

1. Osorio A, et al (2014) PLoS Genet

Funding:

J.B's laboratory, INNPRONTA 2012, Spanish Ministry of Health (PI12/00070) and (CIBERER). C.B is granted by PI12/00070

M.A.B.'s laboratory, Spanish Ministry of Science and Innovation (SAF2008-05384;2007-A-200950) (TELOMARKER), ERCA (GA#232854)

Citation Format: Carlos Benitez-Buelga, Tereza Vaclova, María Sofia Ferreira, Nora Soberon, María Antonia Blasco, Ana Osorio, Javier Benitez. Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2547.

  • ©2016 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 76 (14 Supplement)
July 2016
Volume 76, Issue 14 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 2547: Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 2547: Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers
Carlos Benitez-Buelga, Tereza Vaclova, María Sofia Ferreira, Nora Soberon, María Antonia Blasco, Ana Osorio and Javier Benitez
Cancer Res July 15 2016 (76) (14 Supplement) 2547; DOI: 10.1158/1538-7445.AM2016-2547

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 2547: Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers
Carlos Benitez-Buelga, Tereza Vaclova, María Sofia Ferreira, Nora Soberon, María Antonia Blasco, Ana Osorio and Javier Benitez
Cancer Res July 15 2016 (76) (14 Supplement) 2547; DOI: 10.1158/1538-7445.AM2016-2547
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Epidemiology

  • Abstract SY32-02: Genetic architecture of cancer and other complex diseases: Lessons learned and future directions
  • Abstract SY07-03: Circadian disruption and breast carcinogenesis
  • Abstract SY07-04: Diet and xenobiotic-metabolizing enzymes: Learning from controlled feeding studies in humans
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Genetic Contributions to Cancer Epidemiology: Familial Cancers and GWAS

  • Abstract 2565: Prostate cancer GWAS from more than 89,000 men identifies more than 30 novel prostate cancer susceptibility loci
  • Abstract 2566: Comprehensive analysis to identify functional basis of prostate cancer risk SNPs
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement